|
|
|
Maximizing revenues requires market insight and an understanding of pricing and reimbursement
policies combined with system economics analysis and creative strategic thinking. The
distribution channels and payment rules are different in each segment of the healthcare
industry - drugs, devices, diagnostics and services - but the fundamentals of quantifying
clinical and economic value to determine a product or service’s optimal price and drive
reimbursement coverage apply to all four segments.
Health Advances' reimbursement knowledge is constantly updated by our internal staff. We
have also assembled a panel of external experts, from Medical Directors and Technology
Assessment Executives at regional and national-level payer organizations, to coding and
reimbursement specialists working in hospitals, freestanding clinics, and physician offices,
to third party utilization and preauthorization firms. Each pricing and reimbursement study
leverages these resources to ensure the most up-to-date understanding of the relevant
payments for medical products and services, supported by rigorous comparative cost and
effectiveness research, in order to validate and support pricing decisions and coverage
requests.
- Comparative cost and effectiveness research
- Product launch pricing and positioning
- Payer/provider economics
- Impact of generic and therapeutic substitution
- Reimbursement benchmarking and strategy
- Impact of coverage and reimbursement policy initiatives
|
|
 |
|
|
|
|
|
 download
our our reimbursement brochure. (PDF 653KB)
learn more
about our work in reimbursement and pricing. |
|
|
|
|
 |
|
|
